New test and pill aim to stop leprosy before it starts
NCT ID NCT06222372
Summary
This study aims to prevent leprosy in people who live near someone diagnosed with the disease. Researchers will give a single dose of the antibiotic rifampicin to 1100 contacts in Bangladesh to see if it clears a hidden infection. They will also test a new, simple finger-prick blood test to identify who is infected and needs the preventive treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEPROSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Leprosy Mission International - Bangladesh
RECRUITINGNilphamari, 5300, Bangladesh
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.